Engimmune Therapeutics bg_edited.jpg

Engimmune Therapeutics

Engineering next-generation T cell receptor therapies

News

Engimmune Therapeutics raises EUR 15.2 million in seed financing to develop novel TCR-based therapeutics.

Click on icon to download. 

ETH_Spin-off_Logo_vertikal_positiv.png